Intrinsic Value of S&P & Nasdaq Contact Us

Koninklijke Philips N.V. PHG NYSE

NYSE • Healthcare • Medical - Devices • NL • USD

SharesGrow Score
50/100
2/7 Pass
SharesGrow Intrinsic Value
$42.70
+46.8%
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Koninklijke Philips N.V. (PHG) trades at a trailing P/E of 25.4, forward P/E of 18.8. Trailing earnings yield is 3.94%, forward earnings yield 5.31%. PEG 0.29 (Peter Lynch undervalued ≤1.0). Graham Number is $15.64.

Criteria proven by this page:

  • VALUE (59/100, Partial) — mixed signals — some valuation metrics are favorable while others are stretched.
  • Forward P/E 18.8 (down from trailing 25.4) — analysts expect earnings to grow, which would improve the valuation.
  • PEG Ratio 0.29 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
  • Trailing Earnings Yield 3.94% — roughly competitive with bond yields (~4.3%), moderate risk-reward. Forward yield improves to 5.31% as earnings recover.

Overall SharesGrow Score: 50/100 with 2/7 criteria passed.

SharesGrow 7-Criteria Score
50/100
SG Score
View full scorecard →
~
VALUE
59/100
Price-to-Earnings & upside
Proven by this page
FUTURE
20/100
Analyst consensus
→ Forecast
PAST
25/100
→ Income
~
HEALTH
50/100
Debt-to-Equity & liquidity
→ Health
MOAT
77/100
→ Income
GROWTH
73/100
→ Income
~
INCOME
45/100
→ Income

Valuation Snapshot — PHG

Valuation Multiples
P/E (TTM)25.4
Forward P/E18.8
PEG Ratio0.29
Forward PEG0.29
P/B Ratio2.08
P/S Ratio1.28
EV/EBITDA10.4
Per Share Data
EPS (TTM)$0.94
Forward EPS (Est.)$1.54
Book Value / Share$11.55
Revenue / Share$18.75
FCF / Share$0.74
Yields & Fair Value
Earnings Yield3.94%
Forward Earnings Yield5.31%
Dividend Yield3.55%
Graham Number$15.64
SharesGrow IV$42.70 (+46.8%)

Historical Valuation

Year P/E (TTM) PEG Ratio P/B Ratio P/S Ratio Dividend Yield
2016 17.8 0.14 2.04 1.05 1.28%
2017 17.1 1.33 2.35 1.59 1.36%
2018 25.1 -0.75 2.26 1.51 1.47%
2019 32.5 3.61 3.02 2.22 1.33%
2020 32.8 9.91 3.28 2.25 0.00%
2021 8.2 -0.18 1.89 1.59 2.09%
2022 -8.3 0.02 1.01 0.75 3.25%
2023 -41.6 0.59 1.61 1.07 0.01%
2024 -32.5 -0.61 1.90 1.27 0.00%
2025 24.8 -0.11 2.02 1.24 1.48%

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2016 $1.46 $24.52B $1.45B 5.9%
2017 $1.64 $17.78B $1.66B 9.3%
2018 $1.09 $18.12B $1.09B 6%
2019 $1.20 $19.48B $1.17B 6%
2020 $1.23 $19.54B $1.19B 6.1%
2021 $0.64 $17.16B $612M 3.6%
2022 $-1.84 $17.83B $-1.62B -9.1%
2023 $-0.49 $18.17B $-466M -2.6%
2024 $-0.75 $18.02B $-702M -3.9%
2025 $0.93 $17.83B $895M 5%

Analyst Estimates

Year EPS (Avg) EPS Range Revenue (Avg) Revenue Range Analysts
2026 $1.55 $1.32 – $1.83 $18.2B $17.41B – $18.98B 3
2027 $1.75 $1.51 – $2.08 $19.01B $18.18B – $19.83B 3
2028 $1.96 $1.87 – $2.10 $19.9B $19.23B – $21.04B 1
2029 $2.05 $1.96 – $2.20 $20.6B $19.9B – $21.78B 1
2030 $2.29 $2.19 – $2.46 $21.56B $20.83B – $22.8B 1
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message